Marksans Pharma’s wholly owned subsidiary in UK -- Relonchem has received Marketing Authorization for the product Baclofen 10 mg Tablets from UK Medicines and Healthcare Products Regulatory Agency (UK MHRA).
Earlier, Relonchem had received Marketing Authorization for the product Ibuprofen and Paracetamol 200 mg/500 mg Film-coated Tablets (Bell's Healthcare Dual Action Pain Relief 200 mg/500 mg Film-coated Tablets).
Marksans Pharma is engaged in Research, Manufacturing & Marketing of generic pharmaceutical formulation in the global markets.
